American Journal of Clinical Nutrition, Vol 32, 1477-1485, Copyright © 1979 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand

MF Robinson, PJ Godfrey, CD Thomson, HM Rea and AM van Rij

This study was carried out in Otago, South Island, where most arable land has a low soil selenium content (less than 0.5 microgram/g) and where selenium (Se) responsive diseases in livestock are common. Se concentration in whole blood, erythrocytes and plasma, and activity of glutathione peroxidase (EC 1.11.1.9) were measured in blood from 104 healthy Otago residents, 80 patients with cancer and 66 noncancer surgical patients. The older residents over 60 years had lower blood Se levels (0.047 +/- 0.010 microgram Se/ml blood) than the young and middle-aged (0.060 +/- 0.012 microgram Se/ml). Blood Se levels of cancer patients were no lower than those of elderly subjects and patients without cancer, and were less than half comparable United States values. Blood Se levels were decreasing in two cancer patients, and the lowest values (less than 0.03 microgram Se/ml blood) were obtained for five cancer patients, and two noncancer patients after a long period of inanition; these were similar to values for patients on parenteral nutrition with negligible intakes. Lower blood Se levels were associated with lower serum albumin and enzyme activities. It is suggested that low Se status of cancer patients was more likely a consequence of their illness than the cause of the cancer.

This article has been cited by other articles:

				N. Karunasinghe, L. R. Ferguson, J. Tuckey, and J. Masters Hemolysate Thioredoxin Reductase and Glutathione Peroxidase Activities Correlate with Serum Selenium in a Group of New Zealand Men at High Prostate Cancer Risk J. Nutr., August 1, 2006; 136(8): 2232 - 2235. [Abstract] [Full Text] [PDF]

				G. Ravn-Haren, A. Olsen, A. Tjonneland, L. O. Dragsted, B. A. Nexo, H. Wallin, K. Overvad, O. Raaschou-Nielsen, and U. Vogel Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study Carcinogenesis, April 1, 2006; 27(4): 820 - 825. [Abstract] [Full Text] [PDF]

				N. Karunasinghe, J. Ryan, J. Tuckey, J. Masters, M. Jamieson, L. C. Clarke, J. R. Marshall, and L. R. Ferguson DNA Stability and Serum Selenium Levels in a High-Risk Group for Prostate Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 391 - 397. [Abstract] [Full Text]

				E. J. Ladas, J. S. Jacobson, D. D. Kennedy, K. Teel, A. Fleischauer, and K. M. Kelly Antioxidants and Cancer Therapy: A Systematic Review J. Clin. Oncol., February 1, 2004; 22(3): 517 - 528. [Abstract] [Full Text] [PDF]

				W.C. Willett and M.J. Stampfer Selenium and Human Cancer: Epidemiological Aspects and Implications for Clinical Trials International Journal of Toxicology, January 1, 1986; 5(1): 29 - 36. [PDF]

				A. M. Van Rij, J. M. Mckenzie, C. D. Thomson, and M. F. Robinson Selenium Supplementation in Total Parenteral Nutrition JPEN J Parenter Enteral Nutr, March 1, 1981; 5(2): 120 - 124. [Abstract] [PDF]